Meeting to evaluate safety and toxicity for new drug development
Official title: KICK-OFF MEETING FOR SAFETY EVALUATION AND TOXICOLOGY STUDIES AND RELATED SERVICES FOR DRUG DEVELOPMENT
Funded at Charles River Laboratories Intntl, INC. · NIH-11219841 · Data updated 2026-11-12
This study is all about making sure new medicines are safe for people to use, and it involves planning how to test these drugs so that patients can eventually benefit from safe and effective treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Charles River Laboratories Intntl, INC. NIH-funded |
| Lab location | 1 site (Wilmington, United States) |
| Project start | August 12, 2024 |
| Project end | August 11, 2030 |
| Funding year | 2024 |
| Award (this year) | $1,000 |
| NIH project number | 75N95024D00023-0-759502400001-1 |
| Project ID | NIH-11219841 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit are individuals who may require new drug therapies currently under development.
✕Less likely to help
Patients who are not seeking new drug therapies or those with conditions not addressed by the drugs in development may not receive benefit from this research.
What this research studies
This research involves a kick-off meeting focused on evaluating the safety and toxicology of new drug candidates. The approach includes discussions and planning for comprehensive safety assessments and related services necessary for drug development. Patients may benefit from the outcomes of this research as it aims to ensure that new medications are safe and effective before they reach the market.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective medications for patients.
How similar studies have gone: Similar research efforts in drug safety evaluation have shown success in improving the safety profiles of new medications.
Where this research is happening
-
Charles River Laboratories Intntl, INC.
Wilmington, United States Active
Researchers
- Principal investigator: Stump, Donald — Charles River Laboratories Intntl, INC.
- Study coordinator: Stump, Donald
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.